New England Journal of Medicine · 1984 · 135 citations · 15 references
Life SciencesBiochemistryBiochemical GeneticsClinical NutritionEnzymologyEnzyme DeficienciesLipid Metabolism DisordersMetabolic Pathway DefectsMuscle PathologyMuscular DystrophyAcyl-coa DehydrogenasesEnzyme Deficiency DisordersInherited Metabolic Enzyme DisordersLipid Storage MyopathiesMuscle Enzyme DisordersSkeletal Myopathy
ENGEL and Angelini have reported that skeletal-muscle carnitine deficiency is associated with a lipid-storage myopathy.1 Since then, two major clinical syndromes have been described2: a systemic form, in which carnitine concentrations are low in serum and liver, and a muscular form, in which carnitine concentrations are normal in serum but low in muscle. However, a few patients have the characteristics of both variants, and the two main patient groups have clinically heterogeneous disease, suggesting different biochemical defects. The basic defects causing carnitine deficiency in these syndromes are not known. Hypocarnitinemia also occurs in some inborn errors of metabolism — . . .
15